Your browser doesn't support javascript.
loading
CXCR2 inhibition enables NASH-HCC immunotherapy.
Leslie, Jack; Mackey, John B G; Jamieson, Thomas; Ramon-Gil, Erik; Drake, Thomas M; Fercoq, Frédéric; Clark, William; Gilroy, Kathryn; Hedley, Ann; Nixon, Colin; Luli, Saimir; Laszczewska, Maja; Pinyol, Roser; Esteban-Fabró, Roger; Willoughby, Catherine E; Haber, Philipp K; Andreu-Oller, Carmen; Rahbari, Mohammad; Fan, Chaofan; Pfister, Dominik; Raman, Shreya; Wilson, Niall; Müller, Miryam; Collins, Amy; Geh, Daniel; Fuller, Andrew; McDonald, David; Hulme, Gillian; Filby, Andrew; Cortes-Lavaud, Xabier; Mohamed, Noha-Ehssan; Ford, Catriona A; Raffo Iraolagoitia, Ximena L; McFarlane, Amanda J; McCain, Misti V; Ridgway, Rachel A; Roberts, Edward W; Barry, Simon T; Graham, Gerard J; Heikenwälder, Mathias; Reeves, Helen L; Llovet, Josep M; Carlin, Leo M; Bird, Thomas G; Sansom, Owen J; Mann, Derek A.
Affiliation
  • Leslie J; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Mackey JBG; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Jamieson T; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Ramon-Gil E; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Drake TM; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Fercoq F; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Clark W; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Gilroy K; MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
  • Hedley A; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Nixon C; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Luli S; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Laszczewska M; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Pinyol R; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Esteban-Fabró R; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Willoughby CE; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Haber PK; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Andreu-Oller C; Preclinical In Vivo Imaging Facility, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Rahbari M; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Fan C; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Pfister D; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Raman S; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Wilson N; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Müller M; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Collins A; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Geh D; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Fuller A; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • McDonald D; Division of Chronic Inflammation and Cancer, German Cancer Research Centre, Heidelberg, Germany.
  • Hulme G; Division of Chronic Inflammation and Cancer, German Cancer Research Centre, Heidelberg, Germany.
  • Filby A; Division of Chronic Inflammation and Cancer, German Cancer Research Centre, Heidelberg, Germany.
  • Cortes-Lavaud X; Department of Pathology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Mohamed NE; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Ford CA; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Raffo Iraolagoitia XL; Cancer Research UK Beatson Institute, Glasgow, UK.
  • McFarlane AJ; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • McCain MV; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Ridgway RA; Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Roberts EW; The Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Barry ST; Flow Cytometry Facility, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Graham GJ; Flow Cytometry Facility, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Heikenwälder M; Flow Cytometry Facility, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Reeves HL; Flow Cytometry Facility, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
  • Llovet JM; Innovation, Methodology and Innovation (IMA) theme, Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Carlin LM; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Bird TG; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Sansom OJ; Cancer Research UK Beatson Institute, Glasgow, UK.
  • Mann DA; Cancer Research UK Beatson Institute, Glasgow, UK.
Gut ; 2022 Apr 27.
Article in En | MEDLINE | ID: mdl-35477863
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Gut Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Gut Year: 2022 Document type: Article Affiliation country: Country of publication: